Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | DGKA | P23743 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5029066 | 0.87 | ALDH1A1 (0.45) | LMNAALDH1A1DGKATSHRMAPT | |
| SCHEMBL16607665 | 0.87 | DGKA (0.45) | ALDH1A1DGKAMAPTMGLL | |
| SCHEMBL19169673 | 0.86 | DGKA (0.44) | ALDH1A1DGKAMAPTMGLL | |
| SCHEMBL10081648 | 0.84 | ALDH1A1 (0.43) | ALDH1A1DGKATSHRMAPTMGLL | |
| SCHEMBL5032808 | 0.75 | ALDH1A1 (0.40) | LMNAALDH1A1DGKATSHRFAAH | |
| SCHEMBL18531247 | 0.73 | DGKA (0.44) | LMNAALDH1A1DGKATSHRMAPT | |
| Hydrochloric Acid SCHEMBL421819 | 0.73 | MGLL (0.46) | ALDH1A1DGKAMAPTMGLL | |
| Water SCHEMBL6549696 | 0.73 | MGLL (0.46) | ALDH1A1DGKAMAPTMGLL | |
| Hydrochloric Acid SCHEMBL4074680 | 0.73 | MGLL (0.46) | ALDH1A1DGKAMAPTMGLL | |
| SCHEMBL14956744 | 0.73 | ALDH1A1 (0.66) | LMNAALDH1A1DGKATSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170211016-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN CO (US) | 2017-07-27 | — | — | US | disclosed |
| US-9688944-B2 | Synergistic surfactant blends | STEPAN COMPANY (US) | 2017-06-27 | — | — | US | disclosed |
| US-9688944-B2 | Synergistic surfactant blends | STEPAN COMPANY (US) | 2017-06-27 | — | — | US | disclosed |
| US-20170158617-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN CO (US) | 2017-06-08 | — | — | US | disclosed |
| US-9573884-B2 | Imidazoline amides and derivitives from natural oil metathesis | STEPAN COMPANY (US) | 2017-02-21 | — | — | US | disclosed |
| EP-2632256-B1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN CO (US) | 2017-02-01 | — | — | EP | disclosed |
| US-20150376118-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN CO (US) | 2015-12-31 | — | — | US | disclosed |
| US-9175245-B2 | Fatty amides and derivatives from natural oil metathesis | STEPAN COMPANY (US) | 2015-11-03 | — | — | US | disclosed |
| US-20150094383-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN CO (US) | 2015-04-02 | — | — | US | disclosed |
| WO-2013162924-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN COMPANY (US) | 2013-10-31 | — | — | WO | disclosed |
| US-20130225470-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2013-08-29 | — | — | US | disclosed |
| WO-2012061094-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2012-05-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130225470-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | SGMS1, DEGS1, DGAT2 | LMNA 3734/4885ALDH1A1 671/4885DGKA 149/4885 |
| US-20170158617-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | DEGS1, SGMS1, DGAT2 | LMNA 3964/4885ALDH1A1 656/4885DGKA 127/4885 |
| US-20150094383-A1 | SYNERGISTIC SURFACTANT BLENDS | HHAT, AADAT, SQLE | LMNA 2279/4885ALDH1A1 2198/4885DGKA 1350/4885 |
| US-20150376118-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | DEGS1, SGMS1, DGAT2 | LMNA 3964/4885ALDH1A1 656/4885DGKA 127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.